K Csóka

589 total citations
19 papers, 503 citations indexed

About

K Csóka is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, K Csóka has authored 19 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in K Csóka's work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). K Csóka is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). K Csóka collaborates with scholars based in Sweden, Germany and Norway. K Csóka's co-authors include Peter Nygren, Rolf Larsson, H Fridborg, Sumeer Dhar, Bengt Tholander, Jörgen Kristensen, Kenneth Nilsson, Jan Liliemark, Jonas Bergh and Bertil Jönsson and has published in prestigious journals such as The Journal of Urology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

K Csóka

19 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Csóka Sweden 12 246 207 51 50 47 19 503
H Fridborg Sweden 12 239 1.0× 225 1.1× 60 1.2× 50 1.0× 30 0.6× 20 480
Parul Gupta India 11 260 1.1× 185 0.9× 42 0.8× 41 0.8× 91 1.9× 41 582
Yoshiaki Okuno Japan 20 231 0.9× 248 1.2× 57 1.1× 93 1.9× 78 1.7× 41 796
Satadal Chatterjee United States 14 506 2.1× 360 1.7× 30 0.6× 38 0.8× 35 0.7× 23 656
T. L. Loo United States 10 206 0.8× 175 0.8× 42 0.8× 57 1.1× 115 2.4× 27 522
Andrew D. Louie United States 5 240 1.0× 139 0.7× 36 0.7× 15 0.3× 32 0.7× 7 544
Sayed S. Daoud United States 17 459 1.9× 294 1.4× 45 0.9× 15 0.3× 38 0.8× 38 771
Joanna Regis United States 10 270 1.1× 550 2.7× 71 1.4× 32 0.6× 47 1.0× 14 660
R. J. Hansen United States 12 310 1.3× 190 0.9× 44 0.9× 19 0.4× 74 1.6× 19 574
James A. Rybski United States 10 223 0.9× 278 1.3× 50 1.0× 63 1.3× 27 0.6× 15 574

Countries citing papers authored by K Csóka

Since Specialization
Citations

This map shows the geographic impact of K Csóka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Csóka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Csóka more than expected).

Fields of papers citing papers by K Csóka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Csóka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Csóka. The network helps show where K Csóka may publish in the future.

Co-authorship network of co-authors of K Csóka

This figure shows the co-authorship network connecting the top 25 collaborators of K Csóka. A scholar is included among the top collaborators of K Csóka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Csóka. K Csóka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dhar, Sumeer, Joachim Gullbo, K Csóka, et al.. (2000). Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients. European Journal of Cancer. 36(6). 803–809. 14 indexed citations
2.
Sandström, Marie, K Csóka, Bengt Tholander, et al.. (2000). Evaluation of drug interactions in the established FEC regimen in primary cultures of tumour cells from patients. Annals of Oncology. 11(10). 1301–1308. 5 indexed citations
3.
Nygren, Peter, K Csóka, Rolf Larsson, et al.. (1999). ACTIVITY OF STANDARD AND INVESTIGATIONAL CYTOTOXIC DRUGS IN PRIMARY CULTURES OF TUMOR CELLS FROM PATIENTS WITH KIDNEY AND URINARY BLADDER CARCINOMAS. The Journal of Urology. 162(6). 2200–2204. 7 indexed citations
4.
Csóka, K. (1997). The Fluorometric Microculture Cytotoxicity Assay (FMCA) in assessment of the clinical activity of cytotoxic drugs : with special reference to ovarian carcinoma. 2 indexed citations
5.
Jönsson, E., H Fridborg, K Csóka, et al.. (1997). Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients. British Journal of Cancer. 76(2). 211–219. 38 indexed citations
6.
Dhar, Sumeer, Peter Nygren, K Csóka, et al.. (1996). Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance. British Journal of Cancer. 74(6). 888–896. 69 indexed citations
7.
Jönsson, Bertil, K Csóka, H Fridborg, et al.. (1996). Cytotoxic activity of calcein acetoxymethyl ester (calcein/AM) on primary cultures of human haematological and solid tumours. European Journal of Cancer. 32(5). 883–887. 35 indexed citations
8.
Fridborg, H, Per‐Åke Nygren, Sumeer Dhar, et al.. (1996). In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.. PubMed. 1(5). 286–95. 11 indexed citations
9.
Nygren, Peter, K Csóka, Bertil Jönsson, et al.. (1995). The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. British Journal of Cancer. 71(3). 478–481. 43 indexed citations
10.
Csóka, K, Peter Nygren, Wilhelm Graf, et al.. (1995). Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients. International Journal of Cancer. 63(3). 356–360. 9 indexed citations
11.
Csóka, K, Jan Liliemark, Rolf Larsson, & Peter Nygren. (1995). Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.. PubMed. 22(4 Suppl 11). 47–53. 57 indexed citations
12.
13.
Larsson, Rolf, H Fridborg, Jan Liliemark, et al.. (1994). In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours. European Journal of Cancer. 30(7). 1022–1026. 16 indexed citations
14.
Nygren, Peter, H Fridborg, K Csóka, et al.. (1994). Detection of tumor‐specific cytotoxic drug activity IN VITRO using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients. International Journal of Cancer. 56(5). 715–720. 71 indexed citations
15.
Fridborg, H, Bertil Jönsson, Peter Nygren, et al.. (1994). Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours. British Journal of Cancer. 70(1). 11–17. 29 indexed citations
16.
Larsson, Rolf, et al.. (1992). Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 228(4). 237–240. 8 indexed citations
17.
Fridborg, H, et al.. (1992). Cytotoxic action of cyclosporins on human tumor cell lines is not dependent on immunosuppressive activity.. PubMed. 12(5). 1581–5. 5 indexed citations
18.
Gati, Itamar, et al.. (1990). Effects of prostaglandin and leukotriene inhibitors on the growth of human glioma spheroids. European Journal of Cancer and Clinical Oncology. 26(7). 802–807. 23 indexed citations
19.
Gati, Itamar, et al.. (1990). Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines. Prostaglandins Leukotrienes and Essential Fatty Acids. 40(2). 117–124. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Fridborg Breakdown of academic impact, for papers by Parul Gupta Breakdown of academic impact, for papers by Yoshiaki Okuno Breakdown of academic impact, for papers by Satadal Chatterjee Breakdown of academic impact, for papers by T. L. Loo Breakdown of academic impact, for papers by Andrew D. Louie Breakdown of academic impact, for papers by Sayed S. Daoud Breakdown of academic impact, for papers by Joanna Regis Breakdown of academic impact, for papers by R. J. Hansen Breakdown of academic impact, for papers by James A. Rybski
Rankless by CCL
2026